Skip to main content
NCBI home page
Gut logoLink to Gut
. 1993 Jan;34(1):63–67. doi: 10.1136/gut.34.1.63

Adhesive and hydrophobic properties of Escherichia coli from the rectal mucosa of patients with ulcerative colitis.

M G Hartley 1, M J Hudson 1, E T Swarbrick 1, A E Gent 1, M D Hellier 1, R H Grace 1
PMCID: PMC1374102  PMID: 8432454

Abstract

The adherent properties and hydrophobicity of Escherichia coli isolates have been compared from the rectal mucosa of patients with active and inactive ulcerative colitis and from a control patient group. Patients with active colitis were colonised less frequently and with lower numbers of E coli than were control patients. Mannose resistant adhesion to HEp-2 cells was determined for 124 isolates of E coli and surface hydrophobicity was estimated by salt agglutination in 96 of these isolates. There was no significant difference in the distribution of adherent strains between the colitis patient groups or with disease activity. E coli from the control patients were marginally less adhesive than those from colitics. The hydrophobicity of isolates did not differ significantly between colitic and control groups nor were there significant differences correlated with disease activity. Furthermore, for these mucosal E coli isolates, hydrophobicity and mannose resistant adhesion were unrelated characteristics.

Full text

PDF
63

Images in this article

65Figure 1
on p.65

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Brauner A., Katouli M., Tullus K., Jacobson S. H. Cell surface hydrophobicity, adherence to HeLa cell cultures and haemagglutination pattern of pyelonephritogenic Escherichia coli strains. Epidemiol Infect. 1990 Oct;105(2):255–263. doi: 10.1017/s0950268800047865. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Burke D. A., Axon A. T., Clayden S. A., Dixon M. F., Johnston D., Lacey R. W. The efficacy of tobramycin in the treatment of ulcerative colitis. Aliment Pharmacol Ther. 1990 Apr;4(2):123–129. doi: 10.1111/j.1365-2036.1990.tb00456.x. [DOI] [PubMed] [Google Scholar]
  3. Burke D. A., Axon A. T. Hydrophobic adhesin of E coli in ulcerative colitis. Gut. 1988 Jan;29(1):41–43. doi: 10.1136/gut.29.1.41. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Burke D. A., Axon A. T. Ulcerative colitis and Escherichia coli with adhesive properties. J Clin Pathol. 1987 Jul;40(7):782–786. doi: 10.1136/jcp.40.7.782. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Burke D. A., Clayden S. A., Axon A. T. Sulphasalazine does not select for Escherichia coli with adhesive properties in ulcerative colitis. Lancet. 1988 Oct 22;2(8617):966–966. doi: 10.1016/s0140-6736(88)92636-0. [DOI] [PubMed] [Google Scholar]
  6. Cooke E. M., Ewins S. P., Hywel-Jones J., Lennard-Jones J. E. Properties of strains of Escherichia coli carried in different phases of ulcerative colitis. Gut. 1974 Feb;15(2):143–146. doi: 10.1136/gut.15.2.143. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Cooke E. M. Properties of strains of Escherichia coli isolated from the faeces of patients with ulcerative colitis, patients with acute diarrhoea and normal persons. J Pathol Bacteriol. 1968 Jan;95(1):101–113. doi: 10.1002/path.1700950112. [DOI] [PubMed] [Google Scholar]
  8. Dickinson R. J., Varian S. A., Axon A. T., Cooke E. M. Increased incidence of faecal coliforms with in vitro adhesive and invasive properties in patients with ulcerative colitis. Gut. 1980 Sep;21(9):787–792. doi: 10.1136/gut.21.9.787. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Giaffer M. H., Holdsworth C. D., Duerden B. I. Virulence properties of Escherichia coli strains isolated from patients with inflammatory bowel disease. Gut. 1992 May;33(5):646–650. doi: 10.1136/gut.33.5.646. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Gorbach S. L., Nahas L., Plaut A. G., Weinstein L., Patterson J. F., Levitan R. Studies of intestinal microflora. V. Fecal microbial ecology in ulcerative colitis and regional enteritis: relationship to severity of disease and chemotherapy. Gastroenterology. 1968 Apr;54(4):575–587. [PubMed] [Google Scholar]
  11. Hartley M. G., Hudson M. J., Swarbrick E. T., Hill M. J., Gent A. E., Hellier M. D., Grace R. H. The rectal mucosa-associated microflora in patients with ulcerative colitis. J Med Microbiol. 1992 Feb;36(2):96–103. doi: 10.1099/00222615-36-2-96. [DOI] [PubMed] [Google Scholar]
  12. Kirsner J. B., Shorter R. G. Recent developments in nonspecific inflammatory bowel disease (second of two parts). N Engl J Med. 1982 Apr 8;306(14):837–848. doi: 10.1056/NEJM198204083061404. [DOI] [PubMed] [Google Scholar]
  13. Lindahl M., Faris A., Wadström T., Hjertén S. A new test based on 'salting out' to measure relative surface hydrophobicity of bacterial cells. Biochim Biophys Acta. 1981 Nov 5;677(3-4):471–476. doi: 10.1016/0304-4165(81)90261-0. [DOI] [PubMed] [Google Scholar]
  14. Nataro J. P., Kaper J. B., Robins-Browne R., Prado V., Vial P., Levine M. M. Patterns of adherence of diarrheagenic Escherichia coli to HEp-2 cells. Pediatr Infect Dis J. 1987 Sep;6(9):829–831. doi: 10.1097/00006454-198709000-00008. [DOI] [PubMed] [Google Scholar]
  15. Scaletsky I. C., Silva M. L., Trabulsi L. R. Distinctive patterns of adherence of enteropathogenic Escherichia coli to HeLa cells. Infect Immun. 1984 Aug;45(2):534–536. doi: 10.1128/iai.45.2.534-536.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Swan H. L., Press A. N., Briggs S. L. Child sexual abuse prevention: does it work? Child Welfare. 1985 Jul-Aug;64(4):395–405. [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES